In cancer, the abnormal expression of oncogenic transcription factors (e.g., FLI-1 and ERG) as well as negative regulators of carcinogenesis (e.g., FEV) in the ETS family induces the upregulation of genes that are known to promote cancer and the downregulation of genes that subdue cancer. The gene discussed is ERG; the disease is cancer.